Cargando…
Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing
Until recently, vitamin K antagonists (VKAs) were the mainstay of oral anticoagulant treatment with bleeding as the most prevalent adverse effect. One to four percent of patients experience major bleeding episodes, while clinically relevant bleeding occurs in up to 20%. At this moment no laboratory...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417600/ https://www.ncbi.nlm.nih.gov/pubmed/28472104 http://dx.doi.org/10.1371/journal.pone.0176967 |